Hip News

In this video, Michael A. Mont, MD, FAAOS, discussed a recent consensus on wound and dressing management and how it can reduce variability, advance standardization and improve outcomes for patients undergoing total joint arthroplasty.

The American College of Surgeons released updated guidelines promoting lifelong competency and ability assessments for surgeons to enhance patient safety and preserve “physician dignity,” according to a press release.

Results from a mixed-methods qualitative study showed improvement strategies based on hospital-specific contextual determinants of time to surgery may reduce delays in time to surgery for patients with hip fractures.

Results from this prospective quality control study showed patients who received intrawound vancomycin powder had higher rates of periprosthetic joint infection and reoperations vs. patients who did not receive intrawound vancomycin powder.

Compared with manual total hip arthroplasty, robotic-assisted THA was linked to shorter average length of stay and fewer patients requiring discharge to a skilled nursing facility, according to published results.

Onkos Surgical announced FDA de novo approval of its antibacterial implant coating for use in orthopedic oncology, trauma and revision arthroplasty procedures, according to a company press release.

According to published results, the presence of financial conflicts of interest and industry funding in lower extremity arthroplasty research was associated with favorable conclusions for new technologies.

According to published results, “off-hour” surgical start times between 5 p.m. and 6:59 a.m. do not negatively affect hospital quality measures or outcomes of hip fracture surgery.

Published results showed postoperative mobility was significantly reduced among chronic opioid users who underwent total hip or knee arthroplasty compared with opioid-naïve patients.

Patients who receive combination therapy with paracematol, ibuprofen and dexamethasone demonstrate the lowest morphine consumption in the 24 hours following total hip arthroplasty, according to data published in The Lancet Rheumatology.